Difference between revisions of "Flexible tissues"
Jump to navigation
Jump to search
(Created page with "In flexible (Type F) tissues all cells are assumed to have the potential for proliferation and are also engaged in tissue-specific functions. The pronounced dose-latency relat...") |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
In flexible (Type F) tissues all cells are assumed to have the potential for proliferation and are also engaged in tissue-specific functions. The pronounced dose-latency relationship results from the dose-dependent loss of proliferating functional cells through their mitotic death, together with the feedback-mediated stimulation of compensatory proliferation, leading to an even enhanced cell loss by doomed divisions. | In flexible (Type F) tissues all cells are assumed to have the potential for proliferation and are also engaged in tissue-specific functions. The pronounced dose-latency relationship results from the dose-dependent loss of proliferating functional cells through their mitotic death, together with the feedback-mediated stimulation of compensatory proliferation, leading to an even enhanced cell loss by doomed divisions. | ||
| − | + | '''Return to [[ICRP Glossary|Glossary]]''' | |
| − | ''[[ICRP Glossary]] | ||
Latest revision as of 14:24, 7 September 2021
In flexible (Type F) tissues all cells are assumed to have the potential for proliferation and are also engaged in tissue-specific functions. The pronounced dose-latency relationship results from the dose-dependent loss of proliferating functional cells through their mitotic death, together with the feedback-mediated stimulation of compensatory proliferation, leading to an even enhanced cell loss by doomed divisions.
Return to Glossary
